Events
Calendar of Events
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,PFS & Injectable Drug Devices Europe 2027 will bring together pharmaceutical, biotechnology, medical device and drug delivery professionals in London from 12–14 January 2027 to explore the latest innovations in pre-filled syringes, injectable drug delivery devices, combination products and primary packaging. Now in its 19th year, the conference will provide a focused platform for industry […] |
2 events,The Rational Based Drug Design Summit Europe is the dedicated meeting for structural biologists, biophysicists, medicinal chemists, computational chemists, AI drug discovery experts and pharma leaders advancing next-generation therapeutics. Join Europe's leading biopharma organisations to explore how structural biology, biophysics, medicinal chemistry and AI are accelerating target identification, molecular design and candidate selection through case […] |
0 events,
|
0 events,
|
0 events,
|
|
|
0 events,
|
1 event,The 5th Ophthalmic Drug Delivery Summit is where the innovators behind the next generation of ocular therapies come together to solve one critical challenge: getting the right therapy to the right place in the eye. Hear directly from leaders at Kodiak Sciences, Re-Vana Therapeutics, Ripple Therapeutics, Eli Lilly, Genentech, Sanofi, Astellas, Apellis, Beacon Therapeutics, Kriya […] |
1 event, |
1 event, |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
2 events,Muscular Disorders Drug Development Summit | January 26-28, 2027 | Boston, MA The muscular disease field is entering a pivotal new chapter. Following a year of significant debate around Sarepta's Elevidys, the industry is rapidly evolving as a new wave of gene therapies, RNA medicines, stem cell therapies, and small molecules advance through development. With […] One year on from Vertex Pharmaceuticals' milestone JOURNAVX® approval, making history as the first new class of pain medicine in decades, non-opioid pain R&D has skyrocketed as one of biopharma’s hottest areas for innovation and investment, projected to hit $124bn by 2034. Bringing together 150+ senior leaders across pain biology, drug discovery, translational science, clinical […] |
3 events,The 8th RNAi-Based Therapeutics Summit returns to Boston from January 27-29, 2027, bringing together more than 90 industry experts working across oligonucleotide synthesis, chemistry, biology, molecular design, targeted delivery, translational development, and commercialization. The meeting will provide a focused forum for advancing safer, more potent RNAi therapeutics and expanding their reach beyond traditional liver-directed applications. […] |
1 event, |
0 events,
|
0 events,
|
